Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Lab Anim ; 40(2): 111-4, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16600070

ABSTRACT

In 2003, under the auspices of the main UK funders of biological and biomedical research, a working group was established with a remit to review potential welfare issues for genetically altered (GA) mice, to summarize current practice, and to recommend contemporary best practice for welfare assessments. The working group has produced a report which makes practical recommendations for GA mouse welfare assessment and dissemination of welfare information between establishments using a 'mouse passport'. The report can be found at www.nc3rs.org.uk/GAmice and www.lal.org.uk/gaa and includes templates for the recommended welfare assessment scheme and the mouse passport. An overview is provided below.


Subject(s)
Animal Husbandry/standards , Animal Welfare/standards , Animals, Genetically Modified , Animals , Animals, Laboratory , Guidelines as Topic , Mice
2.
Br J Cancer ; 87(3): 352-8, 2002 Jul 29.
Article in English | MEDLINE | ID: mdl-12177808

ABSTRACT

Ionising radiation is commonly used in the treatment of colorectal cancer. Tumour cells with mutant p53 undergo cell cycle arrest at G2/M after ionising radiation and evidence suggests that abrogation of this G2 arrest can lead to a premature, aberrant mitosis, thus enhancing ionising radiation-induced cell killing. The G2 checkpoint inhibitor UCN-01 was thus investigated to determine whether it would abrogate the G2 checkpoint induced by 5 Gy ionising radiation in a range of colorectal tumour cell lines. Data presented show that, at doses that are alone non-toxic to the cells, UCN-01 inhibits the ionising radiation-induced G2 checkpoint in five colorectal tumour cell lines with mutant p53. The ability of UCN-01 to sensitise cells to ionising radiation-induced growth inhibition and apoptosis was also investigated and UCN-01 was found to radiosensitise two out of five cell lines. These results were confirmed by long-term colony forming efficiency studies. These results demonstrate that abrogation of the ionising radiation-induced G2 checkpoint is not necessarily associated with sensitisation to ionising radiation, however, some colorectal tumour cell lines can be radiosensitised by UCN-01. Although the mechanism of radiosensitisation is not clear, this may still be an important treatment strategy.


Subject(s)
Alkaloids/pharmacology , Antineoplastic Agents/pharmacology , Colorectal Neoplasms/radiotherapy , Enzyme Inhibitors/pharmacology , G2 Phase/radiation effects , Radiation-Sensitizing Agents/pharmacology , Colorectal Neoplasms/pathology , Dose-Response Relationship, Drug , G2 Phase/drug effects , Humans , Staurosporine/analogs & derivatives , Tumor Cells, Cultured , Tumor Stem Cell Assay
SELECTION OF CITATIONS
SEARCH DETAIL
...